Skip Navigation



American Journal of Epidemiology Advance Access published online on August 4, 2007
American Journal of Epidemiology, doi:10.1093/aje/kwm167
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Web Table 1
Right arrow All Versions of this Article:
166/7/741    most recent
kwm167v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sanderson, S.
Right arrow Articles by Higgins, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanderson, S.
Right arrow Articles by Higgins, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology © The Author 2007. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Joint Effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) Genes and Smoking on Bladder Carcinogenesis: A Literature-based Systematic HuGE Review and Evidence Synthesis

Simon Sanderson1,2, Georgia Salanti2,3 and Julian Higgins2,3

1 Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom
2 National Health Service Public Health Genetics Unit, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom
3 Medical Research Council Biostatistics Unit, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom

Correspondence to Dr. Simon Sanderson, Strangeways Research Laboratories, Institute of Public Health, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, United Kingdom (e-mail: simon.sanderson{at}phgfoundation.org).

Received for publication April 25, 2006. Accepted for publication March 30, 2007.

Bladder cancer is an increasingly important international public health problem, with over 330,000 new cases being diagnosed each year worldwide. In a systematic review and evidence synthesis, the authors investigated the joint effects of the N-acetyltransferase genes NAT1 and NAT2 and cigarette smoking on bladder carcinogenesis. Studies were identified through an exhaustive search of multiple electronic databases and reference lists and through direct contact with study authors and experts. Random-effects meta-analysis was used within a Bayesian framework to investigate individual effects of NAT1 and NAT2 acetylation status on bladder cancer risk, while a novel approach was used to investigate joint effects of these two genes with cigarette smoking. An increased risk of bladder cancer was found in NAT2 slow acetylators (odds ratio = 1.46, 95% credible interval (CI): 1.26, 1.68) but not in NAT1 fast acetylators (odds ratio = 1.01, 95% CI: 0.86, 1.22). The joint effects in the highest risk category (NAT2 slow acetylator, NAT1 fast acetylator, and current or ever cigarette smoking) as compared with the reference category (NAT2 fast acetylator, NAT1 slow acetylator, and never smoking) were associated with an odds ratio of 2.73 (95% CI: 1.70, 4.31). The importance of considering joint effects between genetic and environmental factors in the etiology of common complex diseases is underlined.

environmental exposure; genetics; genotype; meta-analysis; N-acetyltransferase 1; NAT2 protein, human; smoking; urinary bladder neoplasms

Abbreviations: CI, credible interval; DIC, deviance information criterion; GST, glutathione S-transferase; NAT, N-acetyltransferase

Editor's note: This article also appears on the website of the Human Genome Epidemiology Network (http://www.cdc.gov/genomics/hugenet/default.htm).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anticancer ResHome page
L. FONTANA, L. DELORT, L. JOUMARD, N. RABIAU, R. BOSVIEL, S. SATIH, L. GUY, J.-P. BOITEUX, Y.-J. BIGNON, A. CHAMOUX, et al.
Genetic Polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 Genes and Association with Bladder Cancer Risk in a French Cohort
Anticancer Res, May 1, 2009; 29(5): 1631 - 1635.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Canova, M. Hashibe, L. Simonato, M. Nelis, A. Metspalu, P. Lagiou, D. Trichopoulos, W. Ahrens, I. Pigeot, F. Merletti, et al.
Genetic Associations of 115 Polymorphisms with Cancers of the Upper Aerodigestive Tract across 10 European Countries: The ARCAGE Project
Cancer Res., April 1, 2009; 69(7): 2956 - 2965.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J.-M. Yuan, K. K. Chan, G. A. Coetzee, J.E. Castelao, M. A. Watson, D. A. Bell, R. Wang, and M. C. Yu
Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer
Carcinogenesis, July 1, 2008; 29(7): 1386 - 1393.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. M. Dong, J. D. Potter, E. White, C. M. Ulrich, L. R. Cardon, and U. Peters
Genetic Susceptibility to Cancer: The Role of Polymorphisms in Candidate Genes
JAMA, May 28, 2008; 299(20): 2423 - 2436.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.